COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS

• 收藏
• 分享

专利权人:

MITSUBISHI TANABE PHARMA CORPORATION

发明人:

Kiichiro Ueta,Kenji Arakawa,Yasuaki Matsushita

申请号：

US14472037

公开号：

US20140371162A1

申请日:

2014.08.28

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention relates to combination therapy comprising a DPP4 inhibitor and an SGLT inhibitor. The combination of the present invention leads to increase plasma GLP-1 level and the combination is useful for prevention or treatment of conditions such as diabetes and diseases related to diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/